EA200000246A1 - Быстро дезинтегрирующие таблетки метилцеллюлозы - Google Patents

Быстро дезинтегрирующие таблетки метилцеллюлозы

Info

Publication number
EA200000246A1
EA200000246A1 EA200000246A EA200000246A EA200000246A1 EA 200000246 A1 EA200000246 A1 EA 200000246A1 EA 200000246 A EA200000246 A EA 200000246A EA 200000246 A EA200000246 A EA 200000246A EA 200000246 A1 EA200000246 A1 EA 200000246A1
Authority
EA
Eurasian Patent Office
Prior art keywords
quickly disintegrating
metal cellulose
cellulose tablets
disintegrating metal
tablets
Prior art date
Application number
EA200000246A
Other languages
English (en)
Other versions
EA004803B1 (ru
Inventor
Брюс Дэджи
Нареш И. Мета
Прийасхри Найак
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA200000246A1 publication Critical patent/EA200000246A1/ru
Publication of EA004803B1 publication Critical patent/EA004803B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Данное изобретение относится к новой фармацевтической композиции и к способу получения таблеток метилцеллюлозы для перорального введения, которые быстро дезинтегрируют и удовлетворяют стандартам Фармакопеи США в 0,1 N соляной кислоте и в воде.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000246A 1997-08-22 1998-08-21 Быстро дезинтегрирующая таблетка метилцеллюлозы и способы ее получения EA004803B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5689997P 1997-08-22 1997-08-22
US8766298P 1998-06-02 1998-06-02
PCT/US1998/017405 WO1999009958A1 (en) 1997-08-22 1998-08-21 Rapidly disintegrating methylcellulose tablets

Publications (2)

Publication Number Publication Date
EA200000246A1 true EA200000246A1 (ru) 2000-08-28
EA004803B1 EA004803B1 (ru) 2004-08-26

Family

ID=26735831

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000246A EA004803B1 (ru) 1997-08-22 1998-08-21 Быстро дезинтегрирующая таблетка метилцеллюлозы и способы ее получения

Country Status (16)

Country Link
US (9) US6350469B1 (ru)
EP (1) EP1005329A4 (ru)
JP (1) JP2001513545A (ru)
KR (3) KR20070040424A (ru)
CN (2) CN1660054A (ru)
AR (1) AR017512A1 (ru)
AU (1) AU741326B2 (ru)
BR (1) BR9811980A (ru)
CA (1) CA2301135C (ru)
CO (1) CO4960651A1 (ru)
EA (1) EA004803B1 (ru)
MY (2) MY135183A (ru)
NZ (1) NZ502891A (ru)
PL (1) PL338858A1 (ru)
TW (1) TWI222869B (ru)
WO (1) WO1999009958A1 (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
JP2002524410A (ja) * 1998-09-08 2002-08-06 スミスクライン・ビーチャム・コーポレイション リプスタチン誘導体−可溶性繊維錠剤
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
CN100387225C (zh) * 1999-12-20 2008-05-14 汉高两合股份公司 稠化体系的制片方法
DE50014807D1 (de) 1999-12-20 2008-01-03 Henkel Kgaa Festförmiges färbemittel für keratinfasern
DE19961910A1 (de) 1999-12-20 2001-06-21 Henkel Kgaa Färbemittel
EP1242037B1 (de) 1999-12-20 2007-07-11 Henkel Kommanditgesellschaft auf Aktien Festförmiges färbemittel für keratinfasern
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
RU2005108609A (ru) * 2002-09-28 2006-03-10 МакНЕЙЛ-ППС, ИНК. (US) Лекарственные формы с модифицированным высвобождением, имеющие два ядра и отверстие
US7232577B2 (en) * 2002-10-21 2007-06-19 L. Perrigo Company Readily dispersible dietary fiber composition
US20040197284A1 (en) * 2003-04-04 2004-10-07 Frederic Auguste Cosmetic composition comprising a volatile fatty phase
MXPA06000702A (es) * 2003-07-23 2006-04-11 Perrigo L Co Composicion que contiene fibra celulosica.
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
JP2005272408A (ja) * 2004-03-26 2005-10-06 Tendou Seiyaku Kk 緩下剤
WO2005107722A2 (en) * 2004-05-04 2005-11-17 Rhodia Inc. Directly compressible tricalcium phosphate
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PL2561766T3 (pl) 2006-11-07 2018-06-29 The Procter And Gamble Company Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
KR100895942B1 (ko) * 2007-05-08 2009-05-07 조선대학교산학협력단 생약 추출물을 함유하는 구강 내 속붕해성 제제 조성물 및그의 제조 방법
WO2009021127A2 (en) * 2007-08-07 2009-02-12 Neurogen Corporation Controlled released compositions
US20110097401A1 (en) * 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US8367104B2 (en) * 2009-10-28 2013-02-05 Mcneil-Ppc, Inc. Fast dissolving/disintegrating coating compositions
TWI564008B (zh) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
TR201904884T4 (tr) * 2012-07-27 2019-05-21 Redhill Biopharma Ltd Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇
US10806743B1 (en) * 2017-05-12 2020-10-20 Braintree Laboratories, Inc. Method of administering lactitol to reduce plasma concentration of lactitol
KR20210092613A (ko) 2020-01-16 2021-07-26 안정오 은 생리대 제조방법
IT202100016784A1 (it) * 2021-06-25 2022-12-25 Natural Way Laboratories Srl Composizione per il rilascio di ioni Magnesio

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883327A (en) * 1954-05-03 1959-04-21 Upjohn Co Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3622673A (en) * 1968-11-14 1971-11-23 Upjohn Co 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
DE1931910B2 (de) 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
US3961056A (en) * 1974-02-11 1976-06-01 The Upjohn Company Substituted morpholine guanidines for the treatment of arrhythmic conditions
US3968211A (en) * 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
JPS5438167B2 (ru) * 1974-04-27 1979-11-19
US4048331A (en) * 1974-10-15 1977-09-13 The Upjohn Company Process of treatment
US3969504A (en) * 1975-02-14 1976-07-13 The Upjohn Co. 6-Phenyl benzodiazepine antidepressants
US4048878A (en) * 1976-04-05 1977-09-20 Dresser Industries, Inc. Slip-type pliers tool
US4148879A (en) * 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4148878A (en) * 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphoric acid esters
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS58144316A (ja) 1982-02-18 1983-08-27 Chiyoda Yakuhin Kk 安定なインドメタシン錠
US4508726A (en) * 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
ZA841044B (en) 1983-02-17 1984-09-26 Merrell Dow Pharma Dry mix cellulose ether compositions as bulk laxatives
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
JPS6028915A (ja) 1983-07-26 1985-02-14 Eisai Co Ltd ユビデカレノン高含量含有組成物
US4476134A (en) * 1983-08-01 1984-10-09 The Upjohn Company Process for treating panic disorders
US4849229A (en) * 1984-03-26 1989-07-18 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
JPS6281324A (ja) * 1985-10-03 1987-04-14 Senjiyu Seiyaku Kk 脂肪組織分解剤
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
SE8601624D0 (sv) 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
JPH0618774B2 (ja) 1986-10-09 1994-03-16 塩野義製薬株式会社 糖衣錠の製造方法
WO1988004292A1 (en) 1986-12-11 1988-06-16 The Upjohn Company Antipsychotic amino-polyhydro-benz-(iso)quinolines and intermediates
JPS63222112A (ja) 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性顆粒
JPS63280023A (ja) 1987-05-11 1988-11-17 Yoshitomi Pharmaceut Ind Ltd 抗リウマチ薬
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
JPH01168619A (ja) 1987-12-24 1989-07-04 Takada Seiyaku Kk 新規な酢酸クロルマジノン固形製剤
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
EP0487774B1 (en) 1990-11-29 1994-10-26 Wei Ming Pharmaceutical Mfg. Co. Ltd. A direct tabletting auxiliary
JPH0515319A (ja) 1990-12-14 1993-01-26 Sunstar Inc 水難溶性塩類の分散法およびそれを分散してなる飲用組成物
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5403593A (en) * 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms
JPH05139973A (ja) 1991-11-20 1993-06-08 Shin Etsu Chem Co Ltd ニフエジピン含有固形製剤の製造方法
WO1993013756A1 (en) * 1992-01-10 1993-07-22 Obschestvo S Ogranichennoy Otvetstvennostyu Meditsinsky Nauchno-Proizvodstvennoy Komplex 'biotiki' Granulated pharmaceutical composition and method of obtaining it
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
DE4333190C2 (de) 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5496884A (en) * 1993-11-12 1996-03-05 Lord Corporation Aqueous adhesive for bonding elastomers
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
JPH07267850A (ja) 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA

Also Published As

Publication number Publication date
MY128046A (en) 2007-01-31
TWI222869B (en) 2004-11-01
EA004803B1 (ru) 2004-08-26
US20050089563A1 (en) 2005-04-28
KR20010023197A (ko) 2001-03-26
AU9202298A (en) 1999-03-16
JP2001513545A (ja) 2001-09-04
AR017512A1 (es) 2001-09-12
US6350469B1 (en) 2002-02-26
EP1005329A1 (en) 2000-06-07
KR20070116291A (ko) 2007-12-07
US20020086052A1 (en) 2002-07-04
WO1999009958A1 (en) 1999-03-04
BR9811980A (pt) 2000-08-15
CA2301135C (en) 2007-04-24
US20030215505A1 (en) 2003-11-20
CA2301135A1 (en) 1999-03-04
US20050089565A1 (en) 2005-04-28
CO4960651A1 (es) 2000-09-25
CN1276719A (zh) 2000-12-13
NZ502891A (en) 2002-06-28
EP1005329A4 (en) 2006-06-14
AU741326B2 (en) 2001-11-29
US20050089561A1 (en) 2005-04-28
KR100743767B1 (ko) 2007-07-30
PL338858A1 (en) 2000-11-20
US20050089560A1 (en) 2005-04-28
US20050089564A1 (en) 2005-04-28
CN1660054A (zh) 2005-08-31
CN1215833C (zh) 2005-08-24
KR20070040424A (ko) 2007-04-16
MY135183A (en) 2008-02-29
US20050089562A1 (en) 2005-04-28
US7125562B2 (en) 2006-10-24

Similar Documents

Publication Publication Date Title
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
YU92501A (sh) Levodop/karbidop/entakapon farmaceutski preparat
HK1067544A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
EP1035838A4 (en) PHARMACEUTICAL SUSPENSION TABLET COMPOSITIONS
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP1246622A4 (en) NEW SUBSTITUTED DOSE FORMS OF BENZIMIDAZOLENES AND METHOD FOR THE USE THEREOF
PL343771A1 (en) N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
FI971172A (fi) Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
BR0117147A (pt) preparado de dosagem oral de desintegração instantánea
DK1073456T3 (da) Anvendelse af osteoprotegerin til forebyggelse og behandling af kardiovaskulære sygdomme
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
SE8901003L (sv) Snabbloesliga preparat
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
GEP20043377B (en) Pharmaceutical Complex
EA200600156A1 (ru) Пероральная дозировочная форма саквинавирмезилата
AR002728A1 (es) Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida.
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU